ChREBP drives diabetic kidney disease, and its inhibition confers renal protection

Chronic kidney disease (CKD) represents a major medical burden. Diabetic kidney disease (DKD) is a leading cause of CKD, but intracellular pathways that can be pharmacologically targeted are poorly defined. Using transcriptome screening of DKD model mice we found that a carbohydrate-responsive element-binding protein (ChREBP)-dependent transcriptional cascade is markedly up-regulated in diabetic kidneys. Genetic ablation of ChREBP in diabetic mice ameliorated DKD, establishing ChREBP as a potential causal driver. A chemical screen based on ChREBP transcriptional activity identified D-532 as a small-molecule inhibitor that is effective in human and rodent cells. Oral administration of D-532 protected multiple diabetic mouse models from DKD progression and suppressed ChREBP and its downstream targets, including genes associated with excessive reactive oxygen species production. These findings position ChREBP as a pharmacologically targetable transcriptional driver of DKD and provide proof of concept that ChREBP inhibition can confer renal protection.

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-11-13
DOI
https://doi.org/10.1073/pnas.2537870123
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ChREBP drives diabetic kidney disease, and its inhibition confers renal protection

Yotaro Matsumoto, Susumu Suzuki, Shigeaki Kato, Atsushi Yokoyama et al.
1 links
Proceedings of the National Academy of Sciences
Chronic Kidney Disease and Diabetes
article

ChREBP drives diabetic kidney disease, and its inhibition confers renal protection

Yotaro Matsumoto, Susumu Suzuki, Shigeaki Kato, Atsushi Yokoyama, Koji Okamoto, Genki Kudo, Hiroyuki Yamakoshi, Ryo Ito, Kosuke Ohsawa, Takatsugu Hirokawa, Tatsuya Takemoto, Shun Sawatsubashi, Akira Sugawara, Yoshiharu Iwabuchi, Yusuke Sasano, Takumi Kouketsu, Yuta Yoshizaki, Takayuki Doi, Kotone Teshima, Thanh Phuong Nguyen, Tomohiro Konno, Mayu Kuroda, Masaya Takahashi, Hiroto Mizuno, Sora Fujita
article en

Abstract

Chronic kidney disease (CKD) represents a major medical burden. Diabetic kidney disease (DKD) is a leading cause of CKD, but intracellular pathways that can be pharmacologically targeted are poorly defined. Using transcriptome screening of DKD model mice we found that a carbohydrate-responsive element-binding protein (ChREBP)-dependent transcriptional cascade is markedly up-regulated in diabetic kidneys. Genetic ablation of ChREBP in diabetic mice ameliorated DKD, establishing ChREBP as a potential causal driver. A chemical screen based on ChREBP transcriptional activity identified D-532 as a small-molecule inhibitor that is effective in human and rodent cells. Oral administration of D-532 protected multiple diabetic mouse models from DKD progression and suppressed ChREBP and its downstream targets, including genes associated with excessive reactive oxygen species production. These findings position ChREBP as a pharmacologically targetable transcriptional driver of DKD and provide proof of concept that ChREBP inhibition can confer renal protection.

Proceedings of the National Academy of SciencesVol. 123(46)
Fukushima Medical University (JP), University of Tsukuba (JP), Okayama University (JP), Tohoku University (JP), Juntendo University (JP), Transborder Medical Research Center (JP), Institute of Advanced Medical Sciences, Tokushima University (JP), Tokushima University (JP)
Suzuken Memorial Foundation, Japan Agency for Medical Research and Development, Takeda Medical Research Foundation, Manpei Suzuki Diabetes Foundation, Japan Society for the Promotion of Science, Institute for Enzyme Research, University of Tokushima
Good health and well-being
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon